You are using an outdated browser. For a faster, safer browsing experience, upgrade for free today.

About Us

Overview

Akaeso Pharmaceuticals is a Belgian drug development company specializing in novel therapeutics for rare and incurable diseases, with a specific focus on fibrotic conditions. Our unique business model eliminates the need for costly in-house drug discovery capabilities, allowing us to collaborate with leading research institutions and companies. Through strategic partnerships, we license innovative drug candidates and assume responsibility for their development, reaching the inflection point where corporate deals with pharmaceutical giants become possible. By capitalizing on protected intellectual property and leveraging the expertise of contract research organizations, we minimize costs and maintain a flexible structure. Our commitment to addressing unmet medical needs drives us to advance treatments for diseases such as liver fibrosis, kidney fibrosis, cystic fibrosis, idiopathic pulmonary fibrosis, myocardial fibrosis, and scleroderma. With a focus on rare and challenging conditions, Akaeso is dedicated to bringing hope and improved quality of life to patients worldwide.

Our strengths

Clear Strategy

We have a clear strategy of focusing on in-licensing and developing novel drugs and entering into corporate deals with pharma companies for finalising development and commercialisation.

Development Capabilities

Akaeso offers extensive drug development capabilities, leveraging strategic collaborations and contract research organizations to advance innovative therapies to reachi inflection points.

Experienced Team

We have experience of over 30 years' each and come from the pharma & biotech industry, science/medicine and finance. We have an entrepreneurial culture and a large network.

Contact us

We care

Our Vision & Values

Akaeso's vision is to become a successful biotech company with disruptive treatments to help millions of sufferers around the world, capitalizing on partnerships and delivering value to our shareholders.

We value innovation, creativity, integrity, commitment and fairness. We believe that success is driven by good people and diversity focusing on talent and experience. We are driven by passion and professionalism.

Power of Collaboration: Accelerating Development

In the dynamic landscape of the pharmaceutical industry, collaborations play a vital role in driving innovation and bringing transformative therapies to patients. Akaeso understands the power of partnerships and embraces a collaborative approach to drug development. We recognize that approximately 30-40% of drugs in the pipelines of major pharmaceutical companies are licensed from biotech counterparts. Our open-minded and collaborative mindset allows us to navigate the complexities of drug development, maximize success rates, and ultimately deliver life-changing treatments to those who need them most.

Alzheimer’s, Parkinson’s, Multiple Sclerosis, Amyotrophic Lateral Sclerosis, Motor Neuron Disease, Frontotemporal Dementia, new drugs

Leadership & Management

Team

Akaeso is managed and supported by an highly experienced Board of Directors, Scientific Advisory Board and Management Team, with each member typically having over 30 years' experience in its field of expertise.

More soon
drug development company- new drugs

The meaning behind our name

We know our name is a little unusual, but it does have a rationale behind it!

At Akaeso Pharmaceuticals, our name embodies the spirit of healing and innovation. Inspired by Akaeso, the daughter of Hippocrates, the father of medicine, we embrace the legacy of compassionate care and scientific advancement. Just as Akaeso epitomized the art of healing, we strive to pioneer breakthrough therapies that bring hope to patients. Our commitment to pushing boundaries and unlocking new possibilities reflects the essence of our namesake. With Akaeso Pharmaceuticals, you can trust that we are driven by a deep-rooted dedication to improving lives and shaping the future of medicine.